News

Home News

No posts to display

- Advertisement -

APPLE

Hemispherx $HEB Going After Multi-Billion Dollar Immuno-Oncology Market

In this episode of CEOLIVE we’re joined by Mr. Thomas Equels, CEO of Hemispherx Biopharma, which trades on the NYSE under ticker HEB. Hemispherx is...

RECENT POSTS

381cf01438895cab0b3756fba2d0131142708ac5e7aa3f1832